The Federal Trade Commission on Monday sued AbbVie Inc. and other drug companies over allegations they unlawfully sought to delay generic competition for AbbVie's blockbuster testosterone-replacement drug AndroGel.. The commission's lawsuit was the first of its kind since a Supreme Court ruling last year boosted FTC efforts to challenge certain agreements between drug makers that can postpone the introduction of generic drugs.. The...
  